The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation.

aPTT coagulation coagulation waveform fibrin first-derivative curve

Journal

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
ISSN: 1938-2723
Titre abrégé: Clin Appl Thromb Hemost
Pays: United States
ID NLM: 9508125

Informations de publication

Date de publication:
Historique:
entrez: 29 12 2020
pubmed: 30 12 2020
medline: 11 8 2021
Statut: ppublish

Résumé

Clot waveform analysis based on activated partial thromboplastin time (aPTT) is reported to be a useful assay. We attempted to find beneficial parameters with the first-derivative curve. We examined 106 plasma samples with prolonged aPTT and analyzed the first-derivative curve statistically by dividing it into 6 groups (Lupus anticoagulant, Heparin, Direct oral anticoagulants, Factor VIII inhibitor, Hepatic dysfunctions and Factor deficiency). We obtained 7 coordinates for parameter measurement by analyzing the first-derivative curve and set 20 parameters including the velocity axis, the time axis, and area parameters. The distribution was checked by extracting each parameter that showed the most significant difference in the 6 groups. As a result, it was revealed that we could classify aPTT prolongation by using a combination of 3 parameters, the initial-to-peak gradient, the ratio initial-to-intermediate velocity/intermediate-to-peak velocity, and the initial-to-peak area size. We constructed a flowchart combining these 3 parameters and were able to discriminate 75% of the specimens. These parameters derived from the first-derivative curve of clot waveform analysis are useful tools to discriminate aPTT prolongation.

Identifiants

pubmed: 33372824
doi: 10.1177/1076029620978810
pmc: PMC7783875
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1076029620978810

Références

Clin Appl Thromb Hemost. 2018 Oct;24(7):1170-1176
pubmed: 29439640
Thromb Haemost. 2002 Mar;87(3):436-41
pubmed: 11916076
Int J Lab Hematol. 2011 Feb;33(1):67-78
pubmed: 20649909
J Thromb Haemost. 2009 Oct;7(10):1737-40
pubmed: 19624461
Br J Haematol. 1997 Jul;98(1):68-73
pubmed: 9233566
Clin Appl Thromb Hemost. 2018 Jul;24(5):764-770
pubmed: 28884611
J Thromb Haemost. 2013 Jul;11(7):1417-20
pubmed: 23648068
Clin Appl Thromb Hemost. 2006 Apr;12(2):185-92
pubmed: 16708120
Int J Lab Hematol. 2018 Feb;40(1):49-55
pubmed: 28869359
Pediatrics. 1993 Jun;91(6):1147-50
pubmed: 8502518
Blood Coagul Fibrinolysis. 2016 Jun;27(4):474-6
pubmed: 26523912
Rinsho Byori. 2009 Oct;57(10):990-8
pubmed: 19928497
Blood Coagul Fibrinolysis. 2002 Jan;13(1):7-17
pubmed: 11994562
Haemophilia. 2017 Sep;23(5):e427-e435
pubmed: 28750470
Haemophilia. 2008 Jul;14 Suppl 3:83-92
pubmed: 18510527
Thromb J. 2019 Jun 28;17:12
pubmed: 31297038
J Thromb Haemost. 2014;12(3):355-62
pubmed: 24354697
J Thromb Haemost. 2006 Feb;4(2):377-84
pubmed: 16420569

Auteurs

Daiki Shimomura (D)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Tomoko Matsumoto (T)

Department of Clinical Laboratory Science, Tenri Health Care University, Tenri City, Nara, Japan.

Kana Sugimoto (K)

Department of Clinical Laboratory Science, Tenri Health Care University, Tenri City, Nara, Japan.

Tokio Takata (T)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Aya Kouno (A)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Masashi Shimada (M)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Shuji Matsuo (S)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Mikio Kamioka (M)

Department of Laboratory Medicine, Tenri Hospital, Tenri City, Nara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH